Role of Purkinje Fibers in the Maintenance of Ventricular Fibrillation
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-09-20
著者
-
Murakawa Yuji
Fourth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine
-
Murakawa Yuji
Fourth Department Of Internal Medicine Mizonokuchi Hospital Teikyo University School Of Medicine
-
Murakawa Yuji
Fourth Department Of Internal Medicine Teikyo University School Of Medicine
関連論文
- Human Atrial Natriuretic Peptide Suppresses Torsades de Pointes in Rabbits
- PJ-434 Vasodilatation Itself Inhibits Ventricular Tachyarrhythmias in Rabbits(PJ073,Arrhythmia, Others (Basic) 1 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- The prognostic significance of the ventricular response during paroxysmal atrial fibrillation
- Role of Purkinje Fibers in the Maintenance of Ventricular Fibrillation
- Effect of Deep Anesthesia on the EAD-Related Polymorphous Ventricular Tachyarrhythmias in Rabbits
- Distinct P Wave during AVNRT Is a Marker of Posterior Fast Pathway
- Effect of Human Atrial Natriuretic Peptide (hANP) on the Ventricular Vulnerability to Torsades de Pointes (TdP) in Rabbits
- OJ-450 Human atrial natriuretic peptide (hANP) and cyclic 3',5'-guanosine monophosphate (cGMP) inhibit the early afterdepolarization-related torsades de pointes (TdP) in rabbits(Arrhythmia, Pharmacological Therapy 5 (A) : OJ55)(Oral Presentation (Japanese
- Deep Anesthesia Suppresses Ventricular Tachyarrhythmias in Rabbit Model of the Acquired Long QT Syndrome
- Focal and Reentrant Mechanisms of Torsades de Pointes : EAD, Reentry, or Chimera?
- A brief report on the nationwide survey of catheter ablation in Japan—Japanese Catheter Ablation Registry (JCAR)—Part 2 Catheter ablation of atrial fibrillation
- A brief report on the nationwide survey of catheter ablation in Japan/the Japanese Catheter Ablation Registry (JCAR)
- Dexmedetomidine and Clonidine Inhibit Ventricular Tachyarrhythmias in a Rabbit Model of Acquired Long QT Syndrome
- Anti-arrhythmic device therapy has limits in improving the prognosis of patients with cardiac amyloidosis
- Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011) : Digest Version